UnitedHealth Stock Recovered Before Its Margins Did

UnitedHealth (UNH) stock has gained about 41% since early March, and at roughly $400 a share the market has already paid for a recovery. The easy reading is that the turnaround is finished. It is not. One half got better over those six months, the other got worse, and the price reflects the good half.

UnitedHealth Got Better In Medicare And In The Clinic

Management planned 2026 around a Medicare medical cost trend of around 10% and now expects to land below it, though the trend is still running well above historical levels. The company names its own benefit design, care management models and network curation as the primary reason, with prior year development and a lighter respiratory season also helping. Medicare margins should finish 2026 above 3%, on a Medicare Advantage book set to shed roughly 1.1 million members.

Optum Health did its work in care delivery rather than plan design. It runs primary and specialist care, ambulatory surgery and home health for 20 million people, and better support for patients moving between care settings has cut hospitalizations by about 10% in its Western and Southern regions since late last year. That is a cost the company took out itself.

But Its Commercial Book Got Worse Over The Same Months

In the commercial business, medical cost trend is running modestly above the 11% management previously saw, and there is still no evidence of it moderating. Two of the drivers stand out.

One is that providers are coding office visits and emergency department encounters more intensively. The other is the arbitration process created by the No Surprises Act: UnitedHealthcare noted that roughly 60% of all arbitration cases are brought by just five entities, with prevailing arbiter awards averaging 11 times what Medicare would pay. Management sizes that drag at about 50 basis points of incremental trend in 2026, and at least 100 basis points of total cost.

Management now expects full margin recovery in the commercial book to take past 2027, against its own historic margin of 7% or greater for that group business. The half that has to close the gap now has longer to do it.

So What Does $400 A Share Actually Buy?

UnitedHealth’s company-wide operating margin is 4.8%, against an average of 7.1% over the past three years. That gap is the investment case.

In mid-July, adjusted 2026 earnings guidance moved to $19.50 to $20 a share, and the full-year operating-earnings outlook to at least $12 billion for UnitedHealthcare and at least $2.2 billion for Optum Health. Both operating-earnings figures are segment outlooks, not the whole company, and a market value near $360 billion is already paying for them.

Elevance Health (ELV) returned 41.6% over the same six months, so UnitedHealth was not the only insurer repriced. But Cigna (CI) returned 4.7% over the same window, so the group did not move as one. The 2026 outlook has already been raised and the commercial cost trend has not turned. Whichever moves next decides the rest.

Do You Want To Separate The Good Half From The Bad Half Again?

You know why this one ran, and getting there meant taking the company apart segment by segment.

Handing that work to a system is the alternative. Since its inception, our rule-based High Quality Portfolio has outperformed its benchmark, a blend of three major indices.

Or keep going company by company. Our Guidance-Driven Momentum screen tracks the outlooks that are still climbing, and a raised outlook is also the first thing that can stop.